ASGE Annual GI Advanced Practice Provider Course (On-Demand) - Clinical Case-Based Learning (Day Two) | April 2023-The NordICC Trial and Colorectal Cancer Screening: What Every APP Needs to Know

The NordICC Trial and Colorectal Cancer Screening: What Every APP Needs to Know

Video Transcription

Video Summary

The video summarizes a study called the Nordic trial, which aims to quantify the benefits of colonoscopy in a screening population. The video discusses different screening tests available for colorectal cancer, including colonoscopy, fecal immunochemical test (FIT), and multi-target stool DNA test (ColoGuard). It emphasizes the importance of the adenoma detection rate in colonoscopy and explains that higher detection rates lead to better outcomes. The video also highlights the media's response to the study, cautioning that the interpretation in the media may not always be accurate and that patients often rely on the media for information. It provides recommendations on what patients should know and how referring physicians should understand and interpret the findings of the study. The video concludes by inviting the audience to participate in future educational opportunities and research projects. No credits were mentioned.

Asset Subtitle

Joseph Vicari, MD, MBA, FASGE

Keywords

Nordic trial

colonoscopy benefits

colorectal cancer screening

adenoma detection rate

screening tests

media interpretation